Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “First-line Chemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Not Yet RecruitingNCT06276933
What this trial is testing

Camrelizumab Combined With Chemotherapy ± Thalidomide in First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Lung CancerCamrelizumab
Tongji University 104
Large-scale testing (Phase 3)Not Yet RecruitingNCT07446335
What this trial is testing

A Phase III Study of First-line Anlotinib Combined With Benmelstobart in Patients With Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Advanced Esophageal Squamous Cell Carcinoma
The First Affiliated Hospital of Zhengzhou University 578
Testing effectiveness (Phase 2)Active Not RecruitingNCT05384015
What this trial is testing

Study of Pembrolizumab, Lenvatinib and Chemotherapy Combination in First Line Extensive-stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer Extensive Stage
Fundación GECP 46
Testing effectiveness (Phase 2)Ended earlyNCT06094296
What this trial is testing

BMS-986315 and Nivolumab in Combination With Chemotherapy in Participants With First-line Stage IV or Recurrent Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
NSCLC
Bristol-Myers Squibb 1
Large-scale testing (Phase 3)UnknownNCT00706862
What this trial is testing

Safety and Efficacy of Talactoferrin in Addition to Standard Chemotherapy in Patients With Non-small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Agennix 1,100
Testing effectiveness (Phase 2)Study completedNCT00601159
What this trial is testing

Gemcitabine and Cisplatin as First Line Combination Therapy in Patients With Triple-negative MBC

Who this might be right for
Metastatic Breast Cancer
Fudan University 70
Large-scale testing (Phase 3)Study completedNCT06781073
What this trial is testing

Nimotuzumab in Combined With Chemotherapy for Treatment of IVB Stage,Rrecurrent or Persistent Cervical Carcinoma

Who this might be right for
Cervical Squamous Cell CarcinomaPersistent
Biotech Pharmaceutical Co., Ltd. 118
Testing effectiveness (Phase 2)Study completedNCT00422773
What this trial is testing

Safety of Cetuximab and Oxaliplatin/5-FU/FA/Irinotecan in First-Line Treatment of Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Technische Universität Dresden 21
Not applicableLooking for participantsNCT07247227
What this trial is testing

Real-world First-line Sugemalimab-Chemotherapy in Advanced NSCLC

Who this might be right for
NSCLC
Peking Union Medical College 150
Testing effectiveness (Phase 2)Study completedNCT00568646
What this trial is testing

Phase 2 Study of Oral MKC-1 in Patients With Unresectable or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
CASI pharmaceuticals, Inc. 33
Testing effectiveness (Phase 2)Study completedNCT00915603
What this trial is testing

Trial of Paclitaxel/Bevacizumab +/- Everolimus for Patients With HER2-Negative Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
SCRI Development Innovations, LLC 113
Testing effectiveness (Phase 2)Active Not RecruitingNCT06313970
What this trial is testing

First-line Regimen With QL1706 Plus Chemo ± Bev in PDAC Patients

Who this might be right for
Pancreatic Cancer
Fudan University 58
Testing effectiveness (Phase 2)Ended earlyNCT00760929
What this trial is testing

The Effect of R1507 in Combination With Tarceva (Erlotinib) on Progression-Free Survival in Patients With Stage IIIb/IV Non-Small Cell Lung Cancer (NSCLC).

Who this might be right for
Non-Squamous Non-Small Cell Lung Cancer
Hoffmann-La Roche 171
Testing effectiveness (Phase 2)Study completedNCT01227928
What this trial is testing

Efficacy and Safety of Pazopanib Monotherapy After First-line Chemotherapy in Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Asian Women

Who this might be right for
Neoplasms, Ovarian
GlaxoSmithKline 145
Testing effectiveness (Phase 2)Study completedNCT01336933
What this trial is testing

Combination Chemotherapy and Pralatrexate as First-Line Therapy in Treating Patients With Non-Hodgkin Lymphoma

Who this might be right for
Anaplastic Large Cell LymphomaAngioimmunoblastic T-cell LymphomaHepatosplenic T-cell Lymphoma+1 more
University of Nebraska 34
Large-scale testing (Phase 3)Ended earlyNCT04300114
What this trial is testing

Maintenance Treatment With Fluzoparib in gBRCA/PALB2 Mutated Pancreatic Cancer Whose Disease Has Not Progressed on First Line Platinum-Based Chemotherapy

Who this might be right for
Metastatic Pancreatic Cancer
Jiangsu HengRui Medicine Co., Ltd. 5
Testing effectiveness (Phase 2)Study completedNCT02453009
What this trial is testing

Addition of Enzalutamide to First Line Docetaxel for Castration Resistant Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Santa Chiara Hospital 246
Testing effectiveness (Phase 2)UnknownNCT01526499
What this trial is testing

Docetaxel With or Without Metronomic Cyclophosphamide as First Line Chemotherapy in Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Fudan University 60
Large-scale testing (Phase 3)Looking for participantsNCT06953999
What this trial is testing

A Phase III Study of Ivonescimab + Chemo With/Without AK117 in Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Akeso 999
Testing effectiveness (Phase 2)UnknownNCT03932981
What this trial is testing

First-line Chemotherapy With Temozolomide Alone for Non-enhancing Adult Brainstem Gliomas, With a Diffuse Subtype and Showing Clinical and/or Radiological Infiltrative Pattern of Progression

Who this might be right for
Adult Brainstem Glioma
Assistance Publique - Hôpitaux de Paris 60
Next Page